Delivery Order SPE2DB22D2211-SPE2DB25FSFMG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,114.74 to AmerisourceBergen Drug Corp for the supply of Methylphenidate 5 mg chewable tablets (100-count units) with a completion date of October 24, 2025. This competitive contract award carries a firm fixed price structure with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a $1,053.00 delivery order to AmerisourceBergen Drug Corp for Methylphenidate 2.5 mg chewable tablets (100 count) on September 26, 2025, with completion targeted for September 29, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,852.00 for 100 tablets of Methylphenidate 2.5 mg chewable formulation. This non-set-aside contract was competitively awarded on August 4, 2025, with an ultimate completion date of August 5, 2025. The contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of methylphenidate 5 mg chewable tablets (100-count bottles) with a contract ceiling value of $1,734.28. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 25, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a $1,682.65 delivery order to AmerisourceBergen Drug Corp for methylphenidate 10 mg chewable tablets (100-count units) on December 22, 2025, with a completion date of December 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Methylphenidate HCL chewable tablets 5mg under a firm fixed-price arrangement. The contract, valued at $6,183.26, was competitively awarded without set-aside designation and is scheduled for completion by June 18, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 12, 2025, for the supply of Methylphenidate 5 mg chewable tablets in quantities of 100 units. The contract is valued at $1,516.78 and carries a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. Performance will be completed at the company's corporate headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The Defense Logistics Agency awarded a $2,646.84 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Methylphenidate ER 18 mg on August 11, 2025, with completion expected by August 12, 2025. This is a firm fixed-price, non-set-aside contract awarded competitively. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Methylphenidate ER 18 mg tablets in a quantity of 100 units, valued at $4,817.50. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is scheduled for completion by September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $2,928.65 delivery order to AmerisourceBergen Drug Corp for Methylphenidate ER(LA) 10mg tablets (100-count package) on October 20, 2025, with completion targeted for October 21, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and supports pharmaceutical supply to federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for military and...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSFMGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,720.88 to AmerisourceBergen Drug Corp for the supply of Methylphenidate 10 mg chewable tablets (100-count units) on September 22, 2025, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA Medical Supply Chain. The company's extensive portfolio of federal contract awards encompasses a wide range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized medical devices across multiple therapeutic domains. The SPE2DX prime vendor contract functions as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply military healthcare programs worldwide, with the DLA planning future Pharmaceutical Prime Vendor Global Program Generation V contracts that may involve multiple regional awards among several contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/22/25 |